Mynd.ai, Inc. ("Mynd" or the "Company") (NYSE:MYND) today announced that on May 18, 2026, the Company received a notice (the "Notice") from the New York Stock Exchange Regulation (the "NYSE") indicating that the Company is not in compliance with NYSE American LLC's ("NYSE American") continued listing requirements due to its failure to timely file its Annual Report on Form 20-F for the year ended December 31, 2025 (the "Form 20-F") with the U.S. Securities and Exchange Commission (the "SEC").

The Notice was issued under Section 1007 of the NYSE American Company Guide, which governs late filings with the SEC. Under this rule, the Company has a six-month period from the filing due date of May 15, 2026 (the "Initial Cure Period") to file the Form 20-F and regain compliance. If the Company does not regain compliance within the Initial Cure Period, the NYSE American may, in its sole discretion, grant an additional period of up to six months (the "Additional Cure Period"), or may determine to commence suspension and delisting procedures.

As disclosed in the Form 12b-25 filed by the Company on April 30, 2026, the Company was unable, without unreasonable effort or expense, to file the Form 20-F as a result of delays in reaching conclusions on certain accounting judgments and disclosures required to be included in its financial statements for the fiscal year ending December 31, 2025. The Company is working diligently with its advisors and auditors to complete the Form 20-F and intends to file within the Initial Cure Period. However, there can be no assurance that the Company will ultimately regain compliance with all applicable NYSE American listing standards.

The Notice has no immediate impact on the listing of the Company's American Depositary Shares, which will continue to trade on the NYSE American, subject to the Company's compliance with other continued listing requirements.